Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

CAPS Rating: 2 out of 5

A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases

Recs

0
Player Avatar marsuculix (30.89) Submitted: 1/2/2013 8:01:25 AM : Outperform Start Price: $7.97 ACHN Score: -14.02

outstanding pipeline in an important market segment: HCV

Featured Broker Partners


Advertisement